145 related articles for article (PubMed ID: 32995835)
1. Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss.
Elsawy NA; Mohamed RA; Ghazala RA; Abdelshafy MA; Elnemr R
Rheumatology (Oxford); 2021 Mar; 60(3):1419-1428. PubMed ID: 32995835
[TBL] [Abstract][Full Text] [Related]
2. Cartilage and bone loss in premenopausal women with rheumatoid arthritis: Radiological and laboratory assessments.
Elsawy NA; Ghazala RA; Elnemr R
Int J Rheum Dis; 2023 Nov; 26(11):2195-2205. PubMed ID: 37731289
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
Elsayed SA; Esmail MA; Ali RM; Mohafez OM
Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients.
Hagras A; Mohasseb D; Taleb R; Bastawi R; Elnemr R
Hum Antibodies; 2024; 32(2):75-83. PubMed ID: 38669525
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
[TBL] [Abstract][Full Text] [Related]
7. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
[TBL] [Abstract][Full Text] [Related]
8. Association of serum anti-carbamylated protein antibodies with disease activity and bone loss in rheumatoid arthritis.
Wang L; Hua L; Hong X; Chen F; Du H
Clin Chim Acta; 2023 Jun; 546():117371. PubMed ID: 37127229
[TBL] [Abstract][Full Text] [Related]
9. Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
Amkreutz JAMP; de Moel EC; Theander L; Willim M; Heimans L; Nilsson JÅ; Karlsson MK; Huizinga TWJ; Åkesson KE; Jacobsson LTH; Allaart CF; Turesson C; van der Woude D
Arthritis Rheumatol; 2021 Jun; 73(6):921-930. PubMed ID: 33314699
[TBL] [Abstract][Full Text] [Related]
10. Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor.
Othman MA; Ghazali WSW; Hamid WZWA; Wong KK; Yahya NK
Saudi Med J; 2017 Sep; 38(9):934-941. PubMed ID: 28889152
[TBL] [Abstract][Full Text] [Related]
11. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
Sidiras P; Spruyt D; Gangji V; Imbault V; Sokolova T; Durez P; Communi D; Rasschaert J; Badot V
Scand J Rheumatol; 2021 Mar; 50(2):118-123. PubMed ID: 33025839
[No Abstract] [Full Text] [Related]
13. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
14. Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
Regueiro C; Ortiz AM; Boveda MD; Castañeda S; Gonzalez-Alvaro I; Gonzalez A
PLoS One; 2018; 13(8):e0202583. PubMed ID: 30118518
[TBL] [Abstract][Full Text] [Related]
15. Anti-carbamylated protein and peptide antibodies as potential inflammatory joint biomarkers in the relatives of rheumatoid arthritis patients.
Chila-Moreno L; Rodríguez LS; Bautista-Molano W; Bello-Gualtero JM; Ramos-Casallas A; Romero-Sánchez C
Int J Rheum Dis; 2020 Dec; 23(12):1698-1706. PubMed ID: 33146469
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
[TBL] [Abstract][Full Text] [Related]
17. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
[TBL] [Abstract][Full Text] [Related]
18. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody and metalloproteinase activity in early arthritis.
Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
[TBL] [Abstract][Full Text] [Related]
20. Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.
Montes A; Regueiro C; Perez-Pampin E; Boveda MD; Gomez-Reino JJ; Gonzalez A
PLoS One; 2016; 11(8):e0161141. PubMed ID: 27537849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
